Medical device

• US 6,104,949 A
• Filed: 09/09/1998
• Issued: 08/15/2000
• Est. Priority Date: 09/09/1998
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Vitatron Medical BV
• Inventors: Pitts Crick, Jonathan, Van Oort, Geeske
• Primary Examiner(s): Lateef, Marvin M.
• Assistant Examiner(s): MANTIS MERCADER, ELENI M
• Application Number:
  US09/150,014
• Time in Patent Office: 706 Days
• Field of Search: 600/547, 600/506, 600/536, 324/600, 607/8, 607/9
• US Class Current: 600/547
• CPC Class Codes: A61B 5/103 Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes A61B5/08 takes precedence; measuring aids for tailors A41H1/00; measuring instruments specially adapted for dentistry A61C19/04
• CPC Class Codes: A61B 5/1116 Determining posture transitions
• CPC Class Codes: A61B 5/6869 Heart
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/36535 controlled by body position or posture
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters

Abstract

A device and method useful in the diagnosis and treatment of congestive heart failure. Specifically the present invention senses the trans-thoracic impedance as well as patient posture. By correlating changes in posture with trans-thoracic impedance changes, the present invention is able to diagnose and assess the degree of congestive heart failure. The present invention is described in the context of an implantable pulse generator system, but it may also be practiced in conjunction with various types of implantable devices.

Claims

1. A device for assessing the degree of heart failure in a patient comprising:

means for sensing the trans thoracic impedance;

means for sensing the posture of the patient; and

means for correlating the sensed trans thoracic impedance with the sensed posture to assess the degree of heart failure.

2. The device for assessing the degree of heart failure according to claim 1 wherein the means for sensing the trans-thoracic impedance comprises means for sensing the amount of pulmonary congestion/edema.

3. The device for assessing the degree of heart failure according to claim 2 wherein the means for measuring the trans-thoracic impedance comprises a first electrode adapted to be positioned within a heart of the patient and a second electrode, means for delivering a an excitation current pulse between the first and second electrodes, and means for sensing the impedance in the tissues disposed between the first and second electrodes to the excitation current pulse.

4. The device for assessing the degree of heart failure according to claim 2 wherein the means for sensing the amount of pulmonary congestion/edema comprises means for sensing audible signals indicative of pulmonary congestion/edema.

5. The device for assessing the degree of heart failure according to claim 2 wherein the means for sensing the amount of pulmonary edema comprises ultrasound means for sensing pulmonary edema.

6. The device for assessing the degree of heart failure according to claim 2 wherein the posture sensor comprises an accelerometer.

7. The device for assessing the degree of heart failure according to claim 2 further comprising means for delivering heart failure therapy to the patient.

8. The device for assessing the degree of heart failure according to claim 7 wherein the means for delivering heart failure therapy to the patient comprises feedback means for controlling in time and doses the amount of said delivered heart therapy to the patient in view of the amount of pulmonary congestion/edema sensed.

9. The device for assessing the degree of heart failure according to claim 7 wherein the means for delivering heart failure therapy to the patient comprises means for delivery a drug to the patient.

10. The device for assessing the degree of heart failure according to claim 7 wherein the means for delivering heart failure therapy to the patient comprises means for delivery electrical stimulation to the patient.

11. A device for assessing the degree of heart failure comprising:

means for sensing the trans thoracic impedance over a predetermined period of time;

means for sensing the posture of the patient; and

means for correlating the sensed trans thoracic impedance over a predetermined period of time with the sensed posture to assess the degree of heart failure.

12. The device for assessing the degree of heart failure according to claim 11 wherein the means for sensing the trans thoracic impedance over a predetermined period of time comprises averaging the value of a series of trans thoracic impedance values.

13. A method for assessing the degree of heart failure in a patient sing the steps of:

sensing the trans thoracic impedance;

sensing the posture of the patient; and

correlating the sensed trans thoracic impedance with the sensed posture to assess the degree of heart failure.

14. The method for assessing the degree of heart failure according to claim 13 wherein the step of sensing the trans-thoracic impedance comprises the step of sensing the amount of pulmonary congestion/edema.

15. The method for assessing the degree of heart failure according to claim 14 wherein the step of sensing the amount of pulmonary congestion/edema comprises the step of sensing audible signals indicative of pulmonary congestion/edema.

16. The method for assessing the degree of heart failure according to claim 14 further comprising the step of delivering heart failure therapy to the patient.

17. The method for assessing the degree of heart failure according to claim 16 wherein the step of delivering heart failure therapy to the patient comprises delivering a drug to the patient.

18. The method for assessing the degree of heart failure according to claim 17 wherein the step of delivering a drug to the patient further comprises the step of controlling in time and the amount of said drug in view of the amount of pulmonary congestion/edema sensed.

19. The method for assessing the degree of heart failure according to claim 14 further comprising the step of delivering electrical stimulation to the patient.